SM

Sabby Management Portfolio holdings

AUM $13M
This Quarter Return
+2.36%
1 Year Return
-26.95%
3 Year Return
-56.43%
5 Year Return
-61.92%
10 Year Return
-71.17%
AUM
$186M
AUM Growth
Cap. Flow
+$186M
Cap. Flow %
100%
Top 10 Hldgs %
75.27%
Holding
107
New
46
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 86.27%
2 Energy 0.58%
3 Consumer Staples 0%
4 Industrials 0%
5 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
MDGL icon
26
Madrigal Pharmaceuticals
MDGL
$9.7B
$1.08M 0.07%
+216,268
New +$1.08M
NS
27
DELISTED
NuStar Energy L.P.
NS
$1.08M 0.07%
+23,584
New +$1.08M
TXMD icon
28
TherapeuticsMD
TXMD
$12.7M
$944K 0.06%
+311,584
New +$944K
VIRX
29
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$939K 0.06%
+180,300
New +$939K
LLY icon
30
Eli Lilly
LLY
$661B
$895K 0.06%
+18,222
New +$895K
MNKD icon
31
MannKind Corp
MNKD
$1.69B
$832K 0.06%
+128,007
New +$832K
TEVA icon
32
Teva Pharmaceuticals
TEVA
$21.5B
$813K 0.05%
+20,736
New +$813K
BAX icon
33
Baxter International
BAX
$12.1B
$800K 0.05%
+11,553
New +$800K
MEIP icon
34
MEI Pharma
MEIP
$149M
$760K 0.05%
+106,600
New +$760K
PRTK
35
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$610K 0.04%
+202,036
New +$610K
ATHX
36
DELISTED
Athersys, Inc. Common Stock
ATHX
$499K 0.03%
+300,745
New +$499K
INFI
37
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$474K 0.03%
+29,188
New +$474K
VNDA icon
38
Vanda Pharmaceuticals
VNDA
$279M
$459K 0.03%
+56,843
New +$459K
CDMO
39
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$385K 0.03%
+298,200
New +$385K
NURO
40
DELISTED
NeuroMetrix, Inc. Common Stock
NURO
$357K 0.02%
+178,387
New +$357K
CRDC
41
DELISTED
CARDICA INC COM NEW (DE)
CRDC
$354K 0.02%
+318,984
New +$354K
APEN
42
DELISTED
Apollo Endosurgery, Inc.
APEN
$312K 0.02%
+70,907
New +$312K
QLTI
43
DELISTED
QLT Inc
QLTI
$295K 0.02%
+67,300
New +$295K
PTN
44
DELISTED
Palatin Technologies
PTN
$257K 0.02%
+427,609
New +$257K
ARAY icon
45
Accuray
ARAY
$165M
$244K 0.02%
+42,491
New +$244K
NSPR icon
46
InspireMD
NSPR
$101M
$235K 0.02%
106,800
+106,800
ALNY icon
47
Alnylam Pharmaceuticals
ALNY
$58.6B
0
AZN icon
48
AstraZeneca
AZN
$255B
0
BHC icon
49
Bausch Health
BHC
$2.72B
0
BMY icon
50
Bristol-Myers Squibb
BMY
$96.7B
0